热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
FITC anti-mouse CD4 Antibody
产品名称：
FITC anti-mouse CD4 Antibody
产品类别：
抗体
产品编号：
100509
产品应用：
100509
[价格]
规格 价格 库存
50µg ￥ 420 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
BALB/c mouse thymocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The RM4-5 antibody blocks the binding of GK1.5 antibody and H129.19 antibody to CD4+ T cells, but not RM4-4 antibody. Additional reported applications (for the relevant formats) include: blocking of ligand binding, in vivo depletion of CD4+ cells1, and immunohistochemistry of acetone-fixed frozen tissue sections2,3,11 and paraffin-embedded sections11. Clone RM4-5 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. Instead, acetone frozen or zinc-fixed paraffin sections are recommended. The Ultra-LEAF? Purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 100575 and 100576).

Application References

(PubMed link indicates BioLegend citation)
  1. Kruisbeek AM. 1991. In Curr. Protocols Immunol. pp. 4.1.1-4.1.5. (Block, Deplete)
  2. Nitta H, et al. 1997. Cell Vision 4:73. (IHC)
  3. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045.
  4. Muraille E, et al. 2003. Infect. Immun. 71:2704. (IHC)
  5. León-Ponte M, et al. 2007. Blood 109:3139. (FC)
  6. Bourdeau A, et al. 2007. Blood doi:10.1182/blood-2006-08-044370. (FC)
  7. Matsumoto M, et al. 2007.J. Immunol.178:2499. PubMed
  8. Shigeta A, et al. 2008. Blood 112:4915. PubMed
  9. Zaborsky N, et al. 2010. J. Immunol. 184:725. PubMed
  10. Rodrigues-Manzanet R, et al. 2010. P. Natl Acad Sci USA 107:8706. PubMed
  11. Whiteland JL, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
Product Citations
  1. Sun L, et al. 2021. Cancer Cell. :. PubMed
  2. Xu C, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.071. PubMed
  3. Wang L, et al. 2018. Exp Ther Med. 15:1532. PubMed
  4. Yu HH, et al. 2021. J Am Heart Assoc. 10:e023077. PubMed
  5. Stone VM, et al. 2022. iScience. 25:105070. PubMed
  6. Zhou J, et al. 2019. Immunity. 50:403. PubMed
  7. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  8. Moodley D, et al. 2016. Proc Natl Acad Sci U S A. 113: 9852 - 9857. PubMed
  9. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  10. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  11. Kagoya Y, et al. 2018. Nat Commun. 9:1915. PubMed
  12. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  13. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  14. Gilleron J et al. 2018. Cell reports. 25(12):3329-3341 . PubMed
  15. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  16. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  17. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  18. Li ZX, et al. 2022. Arch Virol. :. PubMed
  19. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  20. Abou-Hamad J, et al. 2022. iScience. 25:105524. PubMed
  21. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  22. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  23. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  24. Lin H, et al. 2020. Front Microbiol. 1.330555556. PubMed
  25. Ogawa M, et al. 2019. J Biol Methods. 5:e102. PubMed
  26. Achmus L, et al. 2020. Front Neurol. 11:577971. PubMed
  27. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  28. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  29. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  30. Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed
  31. Sehnert B, et al. 2022. Front Immunol. 13:921488. PubMed
  32. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  33. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  34. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  35. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  36. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
  37. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  38. Forni MF, et al. 2021. Front Oncol. 11:667715. PubMed
  39. Sundberg T, et al. 2014. Proc Natl Acad Sci U S A. 111:12468. PubMed
  40. Wiesner D, et al. 2015. PLoS Pathog. 11:1004701. PubMed
  41. Graham DB, et al. 2018. Nat Med. 24:1762. PubMed
  42. Terashima Y, et al. 2020. Nat Commun. 11:609. PubMed
  43. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  44. Qi X, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.25. PubMed
  45. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  46. Jackstadt R, et al. 2019. Cancer Cell. 36:319. PubMed
  47. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  48. Gu Y, et al. 2021. Cell Res. Online ahead of print. PubMed
  49. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  50. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  51. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  52. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  53. Liao T, et al. 2017. Front Immunol. 8:1334. PubMed
  54. Duan RN, et al. 2021. J Neuroinflammation. 18:145. PubMed
  55. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  56. Zhang YN, et al. 2020. EBioMedicine. 56:102819. PubMed
  57. Sebastian M, et al. 2016. J Immunol. 196: 144 - 155. PubMed
  58. Wan X, et al. 2018. Nature. 560:107. PubMed
  59. Wheeler MA, et al. 2019. Cell. 176:581. PubMed
  60. Fang E, et al. 2022. MedComm (2020). 3:e117. PubMed
  61. Belgiovine C, et al. 2021. Eur J Immunol. 51:2677. PubMed
  62. Takeshita Y, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  63. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  64. Lischke T, et al. 2013. Infect Immun . 81:4091. PubMed
  65. Alhosaini K, et al. 2021. Brain Sci. :11. PubMed
  66. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  67. Su X, et al. 2022. J Transl Med. 20:378. PubMed
  68. Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed
  69. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  70. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  71. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  72. Lü X, et al. 2021. Exp Ther Med. 22:1005. PubMed
  73. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  74. Aguilera M, et al. 2021. Int J Mol Sci. 22:. PubMed
  75. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  76. Kyburz A, et al. 2017. Clin Exp Allergy. 47:1331. PubMed
  77. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  78. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  79. Tu J, et al. 2022. Mol Ther Nucleic Acids. 27:733. PubMed
  80. Zhou X, et al. 2021. Cell Reports. 34(1):108601. PubMed
  81. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  82. Takenori Inomata, Jing Hua, Antonio Di Zazzo 2016. Sci Rep. 6:39924. PubMed
  83. Kim M, et al. 2018. Immunity. 49:151. PubMed
  84. Papa I, et al. 2017. Nature. 547:318. PubMed
  85. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  86. Zhang J, et al. 2018. Nature. 553:91. PubMed
  87. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  88. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  89. Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
  90. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  91. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  92. Uribe-Herranz M, et al. 2018. JCI Insight. 3. PubMed
  93. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  94. Bao Z, et al. 2020. Ann Transplant. 25:e921287. PubMed
  95. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  96. Bell CR, et al. 2022. Nat Commun. 13:2063. PubMed
  97. de Assis LVM, et al. 2022. Commun Biol. 5:461. PubMed
  98. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  99. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  100. Lu J, et al. 2022. Int J Mol Med. 49:. PubMed
  101. Harrison DK, et al. 2021. Transplantation. 105:540. PubMed
  102. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  103. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  104. Leon-Ponte M, et al. 2006. Blood. 109:3139. PubMed
  105. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  106. Yeon S, et al. 2017. Sci Rep. 10.1038/s41598-017-11492-7. PubMed
  107. Wang X, et al. 2022. Elife. 11:. PubMed
  108. Helfricht A, et al. 2020. J Exp Med. 217:00:00. PubMed
  109. Ren D, et al. 2020. Am J Cancer Res. 2851:10. PubMed
  110. Wheeler MA, et al. 2020. Nature. 578:593. PubMed
  111. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  112. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  113. Gonzalez-Figueroa P, et al. 2021. Cell. 184(7):1775-1789.e19. PubMed
  114. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  115. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  116. Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
  117. Siegmund K, et al. 2011. J Immunol. 186:3452. PubMed
  118. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  119. Ren X, et al. 2021. Cell Death Dis. 12:484. PubMed
  120. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
RRID
AB_312712 (BioLegend Cat. No. 100509) AB_312713 (BioLegend Cat. No. 100510)

Antigen Details

Structure
Ig superfamily, 55 kD
Distribution

Majority of thymocytes, T cell subset

Function
TCR co-receptor, T cell activation
Ligand/Receptor
MHC class II molecule
Cell Type
Dendritic cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Bierer BE, et al. 1989. Annu. Rev. Immunol. 7:579.
3. Janeway CA. 1992. Annu. Rev. Immunol. 10:645.

Gene ID
12504 View all products for this Gene ID
UniProt
View information about CD4 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线